Skip to main content

Want a detailed portfolio tracker?

MBX
NASDAQ
$60.14

MBX Biosciences Inc (MBX)

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. The company is headquartered in Carmel, Indiana.
Website: https://mbxbio.com
Sector:
Healthcare
Industry:
Biotechnology
68 analysts
Buy
Target: $69 (+14.73%)

Market Cap

$2.89B

Free Cash Flow Yield

-2.77%

Beta (5Y)

1.44

Price Chart

Valuation
Market Cap$2.89B
P/B6.15
Profitability
EBITDA-$160M
EPS-$3.49
Financial Health
Free Cash Flow Yield-2.77%
Growth & Risk
Beta (5Y)1.44
Sharpe Ratio1.69